Literature DB >> 19864675

Clinical practice. Postexposure prophylaxis for HIV infection.

Raphael J Landovitz1, Judith S Currier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19864675     DOI： 10.1056/NEJMcp0904189

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

2.  The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study.

Authors:  Julia Ebert; Jan Peter Sperhake; Olaf Degen; Ann Sophie Schröder
Journal:  Forensic Sci Med Pathol       Date:  2018-05-18       Impact factor: 2.007

3.  Nevirapine-induced Stevens-Johnson syndrome following HIV postexposure prophylaxis.

Authors:  Ayman Bannaga; Omar Rahama; Gavin Barlow
Journal:  BMJ Case Rep       Date:  2013-04-25

4.  A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV.

Authors:  Michelle E Roland; Torsten B Neilands; Melissa R Krone; Thomas J Coates; Karena Franses; Margaret A Chesney; James S Kahn; Jeffrey N Martin
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

Review 5.  Preexposure prophylaxis for HIV prevention.

Authors:  Theodoros Kelesidis; Raphael J Landovitz
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

Review 6.  Antiretroviral-based HIV prevention strategies for women.

Authors:  Z Mike Chirenje; Jeanne Marrazzo; Urvi M Parikh
Journal:  Expert Rev Anti Infect Ther       Date:  2010-10       Impact factor: 5.091

7.  Perceived Advantages and Disadvantages of Using Pre-Exposure Prophylaxis (PrEP) among Sexually Active Black Women: An Exploratory Study.

Authors:  Keosha T Bond; Alana J Gunn
Journal:  J Black Sex Relatsh       Date:  2016

Review 8.  Translation of biomedical prevention strategies for HIV: prospects and pitfalls.

Authors:  Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

9.  Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.

Authors:  Kristen Underhill
Journal:  Am J Law Med       Date:  2012

10.  HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

Authors:  Jeanne M Marrazzo; Carlos del Rio; David R Holtgrave; Myron S Cohen; Seth C Kalichman; Kenneth H Mayer; Julio S G Montaner; Darrell P Wheeler; Robert M Grant; Beatriz Grinsztejn; N Kumarasamy; Steven Shoptaw; Rochelle P Walensky; Francois Dabis; Jeremy Sugarman; Constance A Benson
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.